Abstract
Malaria remains an important public health problem in many LMICs, including Kenya – necessitating alternative prevention and control strategies. Malaria human infection studies (HIS) – trials that involve the deliberate infection of healthy volunteers with malaria parasites to assess the efficacy of potential vaccine and drug candidates and to understand the innate and acquired protection against malaria parasites - have become an important approach to fast-track the development of a malaria vaccine. The KEMRI-Wellcome Trust Research Programme (KWTRP) otherwise known as the KEMRI Centre for Geographic Medicine Research (Coast) (KEMRI CGMRC) has developed expertise in setting up and running research on malaria HIS, with two completed and two planned in the coming months. One of the planned studies is an EDCTP-funded Phase IIb malaria vaccine efficacy trial within a HIS. While all scientific proposals at KWTRP are carefully reviewed by national and international science and ethics review bodies and are supported by a well-developed local community engagement platform, research to understand the social, ethical and regulatory issues for HIS from a grounded perspective is in early stages of development, especially in LMICs. Given the particular opportunities provided by the KWTRP’s experience in running HIS, expertise in embedded social science research and the presence of a well-established community engagement platform, we plan to conduct a social science study within the HIS-based Phase IIb malaria vaccine trial. The overall aim is to contribute to the development of locally responsive policies on the ethical conduct of malaria vaccine efficacy studies involving the use of a HIS in Kenya. Data will be collected from a range of HIS stakeholders, including HIS participants, community members, HIS research team, ethics committees, regulatory authorities and policy makers through surveys, interviews, group discussions, participatory workshops, observations and document review. This is an EDCTP-funded Career Development Fellowship project awarded to PCC.
Funder
Wellcome Trust
European and Developing Countries Clinical Trials Partnership
Reference35 articles.
1. Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017.;M Baay;Biologicals.,2018
2. Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017.;M Baay;Biologicals.,2019
3. Ethical criteria for human challenge studies in infectious diseases.;B Bambery;Public Health Ethics.,2016
4. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar.;A Bhattarai;PLoS Med.,2007
5. Deliberative research as a tool to make value judgements.;T Burchardt;Qual Res.,2014